Europe Extracellular Matrix Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Raw Material (Bovine, Porcine, and Other Raw Material), Application (Soft Tissue Repair, Dural Repair, Wound Healing, Cardiac Repair, Pericardial Repair, and Vascular Repair and Reconstruction)

No. of Pages: 134    |    Report Code: TIPRE00027061    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Extracellular Matrix Market

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Europe Extracellular Matrix Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Europe Extracellular Matrix Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Rising Incidences of Cardiovascular Disorders
  • 5.1.2 Increase in vascular reconstruction procedures.
5.2 Market Opportunities
  • 5.2.1 Expansion of applications in soft tissue and cardiac repair.
  • 5.2.2 Advancements in biomaterials for wound healing.
5.3 Future Trends
  • 5.3.1 Shift towards animal-derived and synthetic matrices.
  • 5.3.2 Integration of extracellular matrix with stem cell therapies.
5.4 Impact of Drivers and Restraints

6. Europe Extracellular Matrix Market Regional Analysis

6.1 Europe Extracellular Matrix Market Overview
6.2 Europe Extracellular Matrix Market Revenue 2019-2028 (US$ Thousand)
6.3 Europe Extracellular Matrix Market Forecast Analysis

7. Europe Extracellular Matrix Market Analysis – by Raw Material

7.1 Bovine
  • 7.1.1 Overview
  • 7.1.2 Bovine: Europe Extracellular Matrix Market – Revenue and Forecast to 2031 (US$ Thousand)
7.2 Porcine
  • 7.2.1 Overview
  • 7.2.2 Porcine: Europe Extracellular Matrix Market – Revenue and Forecast to 2031 (US$ Thousand)
7.3 Other Raw Material
  • 7.3.1 Overview
  • 7.3.2 Other Raw Material: Europe Extracellular Matrix Market – Revenue and Forecast to 2031 (US$ Thousand)

8. Europe Extracellular Matrix Market Analysis – by Application

8.1 Soft Tissue Repair
  • 8.1.1 Overview
  • 8.1.2 Soft Tissue Repair: Europe Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
8.2 Dural Repair
  • 8.2.1 Overview
  • 8.2.2 Dural Repair: Europe Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
8.3 Wound Healing
  • 8.3.1 Overview
  • 8.3.2 Wound Healing: Europe Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
8.4 Cardiac Repair
  • 8.4.1 Overview
  • 8.4.2 Cardiac Repair: Europe Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
8.5 Pericardial Repair
  • 8.5.1 Overview
  • 8.5.2 Pericardial Repair: Europe Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
8.6 Vascular Repair and Reconstruction
  • 8.6.1 Overview
  • 8.6.2 Vascular Repair and Reconstruction : Europe Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)

9. Europe Extracellular Matrix Market – Europe Analysis

9.1 Europe
  • 9.1.1 Europe Extracellular Matrix Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 9.1.1.1 Europe Extracellular Matrix Market – Revenue and Forecast Analysis – by Country
  • 9.1.1.1 UK: Europe Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
    • 9.1.1.1.1 UK: Europe Extracellular Matrix Market Breakdown, by Raw Material
    • 9.1.1.1.2 UK: Europe Extracellular Matrix Market Breakdown, by Application
  • 9.1.1.2 Germany: Europe Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
    • 9.1.1.2.1 Germany: Europe Extracellular Matrix Market Breakdown, by Raw Material
    • 9.1.1.2.2 Germany: Europe Extracellular Matrix Market Breakdown, by Application
  • 9.1.1.3 France: Europe Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
    • 9.1.1.3.1 France: Europe Extracellular Matrix Market Breakdown, by Raw Material
    • 9.1.1.3.2 France: Europe Extracellular Matrix Market Breakdown, by Application
  • 9.1.1.4 Russia: Europe Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
    • 9.1.1.4.1 Russia: Europe Extracellular Matrix Market Breakdown, by Raw Material
    • 9.1.1.4.2 Russia: Europe Extracellular Matrix Market Breakdown, by Application
  • 9.1.1.5 Italy: Europe Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
    • 9.1.1.5.1 Italy: Europe Extracellular Matrix Market Breakdown, by Raw Material
    • 9.1.1.5.2 Italy: Europe Extracellular Matrix Market Breakdown, by Application
  • 9.1.1.6 Rest of Europe: Europe Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
    • 9.1.1.6.1 Rest of Europe: Europe Extracellular Matrix Market Breakdown, by Raw Material
    • 9.1.1.6.2 Rest of Europe: Europe Extracellular Matrix Market Breakdown, by Application

10. Competitive Landscape

10.1 Heat Map Analysis
10.2 Company Positioning and Concentration

11. Europe Extracellular Matrix Market Industry Landscape

11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments

12. Company Profiles

12.1 Medtronic
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
12.2 Merck Kgaa
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
12.3 Smith & Nephew
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
12.4 Anteris
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
12.5 Coloplast Group
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments
12.6 Baxter
  • 12.6.1 Key Facts
  • 12.6.2 Business Description
  • 12.6.3 Products and Services
  • 12.6.4 Financial Overview
  • 12.6.5 SWOT Analysis
  • 12.6.6 Key Developments
12.7 DSM
  • 12.7.1 Key Facts
  • 12.7.2 Business Description
  • 12.7.3 Products and Services
  • 12.7.4 Financial Overview
  • 12.7.5 SWOT Analysis
  • 12.7.6 Key Developments
12.8 Cook Biotech
  • 12.8.1 Key Facts
  • 12.8.2 Business Description
  • 12.8.3 Products and Services
  • 12.8.4 Financial Overview
  • 12.8.5 SWOT Analysis
  • 12.8.6 Key Developments

13. Appendix

13.1 About Business Market Insights

The List of Companies - Europe Extracellular Matrix Market

  1. Medtronic
  2. Merck Kgaa
  3. Smith & Nephew
  4. Anteris
  5. Coloplast Group
  6. Baxter
  7. DSM
  8. Cook Biotech